{"certainAgreement":{"otherDetails":"Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrialdisclosure@celgene.com","organization":"Celgene Corporation","phone":"1-888-260-1599","title":"Associate Director, Clinical Trials Disclosure"}}